Lymphedema after surgery for endometrial cancer: Prevalence, risk factors, and quality of life

Obstetrics and Gynecology

Volumn 124, Issue 2 PART1, 2014, Pages 307-315

  Yost, Kathleen J ^a   Cheville, Andrea L ^a   Al Hilli, Mariam M ^a   Mariani, Andrea ^a   Barrette, Brigitte A ^a   McGree, Michaela E ^a   Weaver, Amy L ^a   Dowdy, Sean C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYSTERECTOMY; LOWER EXTREMITY; LYMPH NODE EXCISION; LYMPHEDEMA; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 84905088151     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000372     Document Type: Article

References (32)

1. de Vries M, Hoekstra HJ, Hoekstra-Weebers JE. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol 2009;16:2840-7.
2. Finnane A, Hayes SC, Obermair A, Janda M. Quality of life of women with lower-limb lymphedema following gynecological cancer. Expert Rev Pharmacoecon Outcomes Res 2011;11: 287-97.
3. McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer 2005;104:457-66.
4. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol 2003;13:214-25.
5. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 2003;52:370-9.
6. Yost KJ, Cheville AL, Weaver AL, Al Hilli M, Dowdy SC. Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women. Phys Ther 2013;93:694-703.
7. Khuri SF, Daley J, Henderson WG. The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs. Arch Surg 2002;137:20-7.
8. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphade-nectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005;23:3668-75.
9. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endo-metrial cancer. Gynecol Oncol 2000;76:348-56.
10. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
11. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-44.
12. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 2012;127:5-10.
13. Kumar S, Mariani A, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, et al. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol 2013;130:441-5.
14. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenec-tomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100: 1707-16.
15. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphade-nectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.
16. Convery PA, Cantrell LA, Di Santo N, Broadwater G, Modesitt SC, Secord AA, et al. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma. Gynecol Oncol 2011;123: 65-70.
17. Hidaka T, Kato K, Yonezawa R, Shima T, Nakashima A, Nagira K, et al. Omission of lymphadenectomy is possible for low-risk corpus cancer. Eur J Surg Oncol 2007;33:86-90.
18. Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL, et al. Nodal metastasis risk in endometrioid endo-metrial cancer. Obstet Gynecol 2012;119:286-92.
19. Yanazume S, Saito T, Eto T, Yamanaka T, Nishiyama K, Okadome M, et al. Reassessment of the utility of frozen sections in endometrial cancer surgery using tumor diameter as an additional factor. Am J Obstet Gynecol 2011;204:531.e1-7.
20. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 2013;128:294-9.
21. Frumovitz M, Coleman RC, Soliman PT, Ramirez PT, Levenback CF. A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol 2014;132:275-9.
22. Ballester M, Dubernard G, Lecuru F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011;12:469-76.
23. Hareyama H, Ito K, Hada K, Uchida A, Hayakashi Y, Hirayama E, et al. Reduction/prevention of lower extremity lymphedema after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignancies. Ann Surg Oncol 2012;19:268-73.
24. Todo Y, Yamamoto R, Minobe S, Suzuki Y, Takeshi U, Nakatani M, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 2010;119:60-4.
25. Barlin JN, Khoury-Collado F, Kim CH, Leitao MM Jr, Chi DS, Sonoda Y, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol 2012;125:531-5.
26. Abu-Rustum NR, Barakat RR. Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy. Gynecol Oncol 2007;106:4-5.
27. Todo Y, Kato H, Okamoto K, Minobe S, Suzuki Y, Ohba Y, et al. Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in intermediate-and high-risk endometrial cancer. Gynecol Oncol 2011;122:55-8.
28. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006;103:714-8.
29. Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lym-phedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 2007;109:2607-14.
30. Backes FJ, Brudie LA, Farrell MR, Ahmad S, Finkler NJ, Bigsby GE, et al. Short-and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecol Oncol 2012;125:546-51.
31. Dunberger G, Lindquist H, Waldenstrom AC, Nyberg T, Steineck G, Avall-Lundqvist E. Lower limb lymphedema in gynecological cancer survivors-effect on daily life functioning. Support Care Cancer 2013;21:3063-70.
32. Angioli R, Plotti F, Cafà EV, Dugo N, Capriglione S, Terranova C, et al. Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy. Eur J Obstet Gynecol Reprod Biol 2013;170:539-43.